- Research works
- 0 fractional, all time
- Citations
- 2 7.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Lubris BioPharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Lubris BioPharma (United States) publish most on?
By volume in 2022–2025: Advancements in Transdermal Drug Delivery, Ocular Surface and Contact Lens and Advanced Drug Delivery Systems.
- 1 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
- 2 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
- 3 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
openly available100.0%
World: 28% of research is openly available.
with international co-authors100.0%
World: 19% is written across borders.
Other research institutions in Weston
- Regis College
- Pope St. John XXIII National Seminary
- Phoenicia Biosciences (United States)
- Airborne Research Associates
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.